Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Junctional Bradycardia with Cardiorenal Syndrome

View through CrossRef
Junctional bradycardia occurs when electrical activity at the SA node is disrupted, or there is a conduction block originating from the SA node, or its automaticity is less than the AV node or HIS bundle. A 46-year-old female was referred because of shortness of breath and swollen limbs. The patient has a long history of diabetes and hypertension. She was diagnosed with acute pulmonary edema, junctional bradycardia, stage 4 CKD, CHF, hypoalbuminemia, anemia, and T2DM. The patient was admitted to the ICCU for 7 days before being discharged. Cardiorenal syndrome can induce sinus node dysfunction or AV node dysfunction, leading to junctional bradycardia. Subsequently, the junctional bradycardia exacerbates concomitant heart failure and renal failure.
Title: Junctional Bradycardia with Cardiorenal Syndrome
Description:
Junctional bradycardia occurs when electrical activity at the SA node is disrupted, or there is a conduction block originating from the SA node, or its automaticity is less than the AV node or HIS bundle.
A 46-year-old female was referred because of shortness of breath and swollen limbs.
The patient has a long history of diabetes and hypertension.
She was diagnosed with acute pulmonary edema, junctional bradycardia, stage 4 CKD, CHF, hypoalbuminemia, anemia, and T2DM.
The patient was admitted to the ICCU for 7 days before being discharged.
Cardiorenal syndrome can induce sinus node dysfunction or AV node dysfunction, leading to junctional bradycardia.
Subsequently, the junctional bradycardia exacerbates concomitant heart failure and renal failure.

Related Results

Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies
Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies
Objective To review the current knowledge about the pathophysiological mechanisms, preclinical models, novel contributors and potential therapies of cardiorenal syndrom...
MO667: Creating a New Cardiorenal Unit: 3-Year Study Results
MO667: Creating a New Cardiorenal Unit: 3-Year Study Results
Abstract BACKGROUND AND AIMS Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart...
Incidence and risk factors of bradycardia in pediatric patients undergoing intranasal dexmedetomidine sedation
Incidence and risk factors of bradycardia in pediatric patients undergoing intranasal dexmedetomidine sedation
BackgroundDexmedetomidine is widely used for non‐invasive pediatric procedural sedation. However, the hemodynamic effects of intravenous dexmedetomidine are a concern. There has be...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Analisis Asuhan Keperawatan Pada Pasien Chronic Kidney Disease Dengan Cardiorenal Syndrome di Ruang Intensif Care Unit
Analisis Asuhan Keperawatan Pada Pasien Chronic Kidney Disease Dengan Cardiorenal Syndrome di Ruang Intensif Care Unit
Penyakit ginjal dan jantung merupakan penyakit yang memiliki tingkat morbiditas dan mortalitas yang tinggi. Organ ginjal dan jantung memiliki faktor risiko vaskular yang sama dan s...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract Introduction Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway
Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway
Abstract: The pathogenesis of cardiorenal syndrome (CRS) is very complex, and currently there is no effective treatment for CRS. Higenamine (HI) has been shown to improve...

Back to Top